AZN vs IVVD · P/E 28, $288.38B cap vs rev $14.3M
AstraZeneca PLC (AZN) versus Invivyd Inc. (IVVD) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Invivyd Inc. (IVVD) is a biotechnology company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported IVVD revenue for 2026-06-30 was $14.3M. Net income was -$44.4M. Revenue was up 3.9% from 2026-03-31 to 2026-06-30. IVVD currently screens at market cap $85.8M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. IVVD currently screens at market cap $85.8M.
Not investment advice. Open the AZN and IVVD stock pages for the full models.
Not investment advice.